Mayor Bass taps AECOM to assist with Palisades rebuilding
The firm will work alongside both the city and Hagerty Consulting, which Bass tapped as a recovery contractor in early February, according to the mayor's office.
Hagerty, an Illinois-based disaster recovery firm, has a yearlong contract with the city for up to $10 million but has faced persistent questions about the specifics of its work.
Read more: As L.A. rebuilds from the Palisades fire, residents ask: What's the plan?
The mayor's office did not immediately answer when asked Friday whether Hagerty's role was being scaled back.
In late January, the mayor, along with four council members and other city officials, heard presentations from Hagerty, AECOM and a third firm also seeking to be the city's disaster recovery contractor.
After Bass selected Hagerty in February, she said the city was still in discussions with AECOM about a separate contract.
'An unprecedented natural disaster requires an unprecedented, all-hands-on-deck response — all levels of government, philanthropy, the private sector and educational institutions coming together to support the community and rebuild as quickly and safely as possible,' Bass said in a written statement Friday. 'AECOM's expertise in long-term infrastructure planning and design will only further expedite our work to get families home.'
The mayor's office also did not immediately respond when asked whether the city now has a contract with AECOM, or what the specifics of that contract, including the compensation, are.
Steve Soboroff, a longtime local developer and Bass' former chief recovery officer, publicly criticized Bass' decision to choose Hagerty over AECOM as the city's initial disaster recovery contractor. In an interview in mid-April as he was leaving his post, Soboroff raised questions about Hagerty's role and said he thought AECOM should have been hired instead.
Along with developing a comprehensive rebuilding master plan and supporting the Palisades' infrastructure reconstruction, AECOM will help coordinate broader public and private rebuilding efforts.
The company will work on a "logistics plan for materials management in coordination with local builders and suppliers" as well as a master traffic plan as more homeowners leap into the rebuilding process, according to a news release.
AECOM is also the "official venue infrastructure partner" for the 2028 Olympic Games, according to a March news release from LA28.
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
This story originally appeared in Los Angeles Times.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
What To Expect From AECOM's (ACM) Q2 Earnings
Infrastructure consulting service company AECOM (NYSE:ACM) will be announcing earnings results this Monday after the bell. Here's what to expect. AECOM missed analysts' revenue expectations by 9.5% last quarter, reporting revenues of $3.77 billion, down 4.4% year on year. It was a mixed quarter for the company, with a decent beat of analysts' adjusted operating income estimates. Is AECOM a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting AECOM's revenue to grow 4.1% year on year to $4.32 billion, slowing from the 13.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.26 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AECOM has missed Wall Street's revenue estimates three times over the last two years. Looking at AECOM's peers in the construction and engineering segment, some have already reported their Q2 results, giving us a hint as to what we can expect. EMCOR delivered year-on-year revenue growth of 17.4%, beating analysts' expectations by 4.9%, and MasTec reported revenues up 19.7%, topping estimates by 4.2%. EMCOR traded down 2.3% following the results while MasTec was also down 8%. Read our full analysis of EMCOR's results here and MasTec's results here. Investors in the construction and engineering segment have had steady hands going into earnings, with share prices flat over the last month. AECOM is down 4.7% during the same time and is heading into earnings with an average analyst price target of $124.50 (compared to the current share price of $110). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion
On Thursday, AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus of $14.98 billion. Sales increased 6.6% on a reported basis or 6.5% on an operational basis. The company reported adjusted earnings of $2.97, up 12.1% year over year and missing the consensus of $3.23. AbbVie raised its fiscal 2025 adjusted earnings from $11.67-$11.87 per share to $11.88-$12.08 compared to the analysts' estimate of $12.24.'While management indicated that they expect some moderation in net pricing in the second half, the volume growth we are seeing from these products gives us added confidence in the company's outlook for the second half of 2025 and the coming years,' Guggenheim Partners wrote in an investor note on Thursday. Guggenheim updated its model to reflect the quarterly performance, including higher Skyrizi and neuroscience estimates, a steeper Humira erosion curve, and slightly lower aesthetics estimates, resulting in new 2025E revenue/EPS of $60.69 billion/$12.04, up from $60.02 billion/$11.92, respectively. View more earnings on ABBV Analyst Vamil Divan says Skyrizi and Rinvoq are now tracking ahead of management's prior long-term targets. Guggenheim expects those targets will likely be increased further by the time the company releases its fiscal 2025 earnings in February next year. The analyst reiterates a Buy rating, increasing the price forecast from $216 to $227. 'We acknowledge that the Part D Redesign provision of the Inflation Reduction Act may affect drug prices in an unexpected way in the back half of the we generally do not expect a dramatic increase in pricing pressure on ABBV's portfolio relative to the first half of the year...,' the analyst wrote. Mirroring the positive sentiment, Morgan Stanley has maintained AbbVie as an Overweight and has raised the price forecast from $250 to $255. Price Action: ABBV stock is trading higher by 3.24% to $195.14 at last check Friday. Read Next:Photo via Shutterstock Latest Ratings for ABBV Date Firm Action From To Feb 2022 UBS Downgrades Buy Neutral Feb 2022 Mizuho Maintains Buy Feb 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for ABBV View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
7 hours ago
- CNBC
Delta Air assures US lawmakers it will not personalize fares using AI
Delta Air Lines said on Friday it will not use artificial intelligence to set personalized ticket prices for passengers after facing sharp criticism from U.S. lawmakers and broad public concern. Last week, Democratic Senators Ruben Gallego, Mark Warner and Richard Blumenthal said they believed the Atlanta-based airline would use AI to set individual prices, which would "likely mean fare price increases up to each individual consumer's personal 'pain point.'" Delta said it has not used AI to set personalized prices but previously said it plans to deploy AI-based revenue management technology across 20% of its domestic network by the end of 2025 in partnership with Fetcherr, an AI pricing company. "There is no fare product Delta has ever used, is testing or plans to use that targets customers with individualized prices based on personal data," Delta told the senators in a letter on Friday, seen by Reuters. "Our ticket pricing never takes into account personal data." Senators praised Delta's commitment not to use AI for personal pricing but expressed many questions and want more details about what data Delta is collecting to set prices. "Delta is telling their investors one thing, and then turning around and telling the public another," Gallego said. "If Delta is in fact using aggregated instead of individualized data, that is welcome news." Delta declined comment on Gallego's statement. The senators cited a comment in December by Delta President Glen Hauenstein that the carrier's AI price-setting technology is capable of setting fares based on a prediction of "the amount people are willing to pay for the premium products related to the base fares." Last week, American Airlines CEO Robert Isom said using AI to set ticket prices could hurt consumer trust. "This is not about bait and switch. This is not about tricking," Isom said on an earnings call, adding "talk about using AI in that way, I don't think it's appropriate. And certainly from American, it's not something we will do." Democratic lawmakers Greg Casar and Rashida Tlaib last week introduced legislation to bar companies from using AI to set prices or wages based on Americans' personal data and would specifically ban airlines raising individual prices after seeing a search for a family obituary. They cited a Federal Trade Commission staff report in January that found "retailers frequently use people's personal information to set targeted, tailored prices for goods and services -- from a person's location and demographics, down to their mouse movements on a webpage." The FTC cited a hypothetical example of a consumer profiled as a new parent who could intentionally be shown higher-priced baby thermometers and collect behavioral details to forecast a customer's state of mind. Delta said airlines have used dynamic pricing for more than three decades, in which pricing fluctuates based on a variety of factors like overall customer demand, fuel prices and competition, but not a specific consumer's personal information. "Given the tens of millions of fares and hundreds of thousands of routes for sale at any given time, the use of new technology like AI promises to streamline the process by which we analyze existing data and the speed and scale at which we can respond to changing market dynamics," Delta's letter said.
